RUTGERS UNIVERSITY A Rutgers researcher leading a trial found that the novel combination antibiotic sulbactam-durlobactam combats dangerous pneumonia at least as well as the best currently approved treatment. The findings have led a unanimous expert committee to recommend that the Food and Drug Administration (FDA) approve the new drug, which could be available this summer to combat...
Tag: <span>Novel antibiotic</span>
Post
Novel antibiotic deceives bacteria through mimicry
Most antibiotics need to penetrate their target bacteria. But Darobactin, a newly discovered compound, is much too large to do so. Nonetheless, it kills many antibiotic-resistant pathogens – by exploiting a tiny weak spot on their surface. Researchers at the University of Basel’s Biozentrum have now revealed the amazing mechanism at play and thereby opened the...